Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06146257
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-11-10
Brief Title:
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Sponsor:
GluBio Therapeutics Inc
Organization:
GluBio Therapeutics Inc
Organization Data
Organization:
GluBio Therapeutics Inc
Class:
INDUSTRY
Study ID:
GLB-001-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GluBio Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None